Trial Details
COMPLETEDBasic Information
| Clinical ID | c2987 |
|---|---|
| Identifier | NCT02686138 |
| Trial Title | A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Constipation Predominant Irritable Bowel Syndrome |
| Interventions | DRUG: Tenapanor|DRUG: Placebo |
Participant Information
| Sponsor | Ardelyx |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2015-12 |
|---|---|
| Primary Completion Date | 2017-08 |
| Completion Date | 2017-10 |